Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Camila Xu -- 1556 2022-10-20 01:34:16

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. Aprotinin. Encyclopedia. Available online: https://encyclopedia.pub/entry/30320 (accessed on 25 September 2026).
HandWiki. Aprotinin. Encyclopedia. Available at: https://encyclopedia.pub/entry/30320. Accessed September 25, 2026.
HandWiki. "Aprotinin" Encyclopedia, https://encyclopedia.pub/entry/30320 (accessed September 25, 2026).
HandWiki. (2022, October 20). Aprotinin. In Encyclopedia. https://encyclopedia.pub/entry/30320
HandWiki. "Aprotinin." Encyclopedia. Web. 20 October, 2022.
Aprotinin
Edit
The content is sourced from: https://handwiki.org/wiki/Chemistry:Aprotinin

The drug aprotinin (Trasylol, previously Bayer and now Nordic Group pharmaceuticals), is a small protein bovine pancreatic trypsin inhibitor (BPTI), or basic trypsin inhibitor of bovine pancreas, which is an antifibrinolytic molecule that inhibits trypsin and related proteolytic enzymes. Under the trade name Trasylol, aprotinin was used as a medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use was to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss. The drug was temporarily withdrawn worldwide in 2007 after studies suggested that its use increased the risk of complications or death; this was confirmed by follow-up studies. Trasylol sales were suspended in May 2008, except for very restricted research use. In February 2012 the European Medicines Agency (EMA) scientific committee reverted its previous standpoint regarding aprotinin, and has recommended that the suspension be lifted. Nordic became distributor of aprotinin in 2012.

trasylol aprotinin fibrinolysis

References

  1. "Hemostatic drugs". The New England Journal of Medicine 339 (4): 245–53. July 1998. doi:10.1056/NEJM199807233390407. PMID 9673304.  https://dx.doi.org/10.1056%2FNEJM199807233390407
  2. "Perioperative systemic haemostatic agents". British Journal of Anaesthesia 93 (6): 842–58. December 2004. doi:10.1093/bja/aeh227. PMID 15277296.  https://dx.doi.org/10.1093%2Fbja%2Faeh227
  3. "The anatomy and taxonomy of protein structure". Advances in Protein Chemistry Volume 34. Advances in Protein Chemistry. 34. 1981. pp. 167–339. doi:10.1016/S0065-3233(08)60520-3. ISBN 978-0-12-034234-1.  https://dx.doi.org/10.1016%2FS0065-3233%2808%2960520-3
  4. "The basic trypsin inhibitor of bovine pancreas. IV. The linear sequence of the 58 amino acids". Biochemical and Biophysical Research Communications 18 (2): 255–8. January 1965. doi:10.1016/0006-291X(65)90749-7. PMID 14282026.  https://dx.doi.org/10.1016%2F0006-291X%2865%2990749-7
  5. "The basic trypsin inhibitor of bovine pancreas. V. The disulfide linkages". Biochemical and Biophysical Research Communications 20 (4): 463–8. August 1965. doi:10.1016/0006-291X(65)90601-7. PMID 5860161.  https://dx.doi.org/10.1016%2F0006-291X%2865%2990601-7
  6. "Antifibrinolytics in orthotopic liver transplantation: current status and controversies". Liver Transplantation 11 (1): 10–8. January 2005. doi:10.1002/lt.20275. PMID 15690531.  https://dx.doi.org/10.1002%2Flt.20275
  7. "Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials". The Journal of Thoracic and Cardiovascular Surgery 128 (3): 442–8. September 2004. doi:10.1016/j.jtcvs.2004.03.041. PMID 15354106.  https://dx.doi.org/10.1016%2Fj.jtcvs.2004.03.041
  8. "Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials". Anesthesia and Analgesia 101 (6): 1602–7. December 2005. doi:10.1213/01.ANE.0000180767.50529.45. PMID 16301226.  https://dx.doi.org/10.1213%2F01.ANE.0000180767.50529.45
  9. "The risk associated with aprotinin in cardiac surgery". The New England Journal of Medicine 354 (4): 353–65. January 2006. doi:10.1056/NEJMoa051379. PMID 16436767.  https://dx.doi.org/10.1056%2FNEJMoa051379
  10. "Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery". JAMA 297 (5): 471–9. February 2007. doi:10.1001/jama.297.5.471. PMID 17284697.  https://dx.doi.org/10.1001%2Fjama.297.5.471
  11. Harris, Gardiner (2006-09-30). "F.D.A. Says Bayer Failed to Reveal Drug Risk Study - New York Times". The New York Times. https://www.nytimes.com/2006/09/30/health/30fda.html. 
  12. "Facts & Comparisons: Trasylol Public Health Advisory Update". http://factsandcomparisons.com/News/ArticlePage.aspx?id=7387. 
  13. "Early Communication about an Ongoing Safety Review Aprotinin Injection (marketed as Trasylol)". https://www.fda.gov/cder/drug/early_comm/aprotinin.htm. 
  14. "Information for Healthcare Professionals; Aprotinin (marketed as Trasylol)". https://www.fda.gov/cder/drug/InfoSheets/HCP/aprotininHCP.htm. 
  15. Harris, Gardiner (2007-11-05). "Bayer Withdraws Heart Surgery Drug". The New York Times. https://www.nytimes.com/2007/11/05/health/05cnd-bayer.html?hp. 
  16. "The effect of aprotinin on outcome after coronary-artery bypass grafting". The New England Journal of Medicine 358 (8): 784–93. February 2008. doi:10.1056/NEJMoa0707768. PMID 18287601.  https://dx.doi.org/10.1056%2FNEJMoa0707768
  17. "Aprotinin during coronary-artery bypass grafting and risk of death". The New England Journal of Medicine 358 (8): 771–83. February 2008. doi:10.1056/NEJMoa0707571. PMID 18287600.  https://dx.doi.org/10.1056%2FNEJMoa0707571
  18. "Aprotinin, a carbohydrate-binding protein". Histochemie. Histochemistry. Histochimie 34 (4): 275–80. March 1973. doi:10.1007/BF00306299. PMID 4266832.  https://dx.doi.org/10.1007%2FBF00306299
  19. "Fluorescent-labelled aprotinin: a new reagent for the histochemical detection of acid mucosubstances". Histochemistry 34 (1): 77–84. 1973. doi:10.1007/BF00304309. PMID 4119444.  https://dx.doi.org/10.1007%2FBF00304309
  20. "Über die Inaktivierung des kallikreins" (in de). Hoppe-Seyler's Z Physiol Chem 192: 1–21. 1930. doi:10.1515/bchm2.1930.192.1-3.1.  https://dx.doi.org/10.1515%2Fbchm2.1930.192.1-3.1
  21. "Isolation from beef pancreas of crystalline trypsinogen, trypsin, trypsin inhibitor, and an inhibitor trypsin compound". The Journal of General Physiology 19 (6): 991–1007. July 1936. doi:10.1085/jgp.19.6.991. PMID 19872978.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2141477
  22. "Versuche zur Isolierung des Kallikrein-Inaktivators aus Rinderlunge and seine Identifizierung mit dem Inaktivator aus Rinderparotis" (in de). Hoppe-Seyler's Zeitschrift für Physiologische Chemie 338: 231–7. 1964. doi:10.1515/bchm2.1964.338.1-2.231. PMID 14330402.  https://dx.doi.org/10.1515%2Fbchm2.1964.338.1-2.231
  23. "Early Experience With Trasylol in the Treatment of Acute Pancreatitis". Southern Medical Journal 57 (11): 1317–21. November 1964. doi:10.1097/00007611-196411000-00012. PMID 14195953.  https://dx.doi.org/10.1097%2F00007611-196411000-00012
  24. "The Inhibition of Trasylol of Fibrinolytic Activity Associated With Cardiovascular Operations". Surgery, Gynecology & Obstetrics 119: 71–4. July 1964. PMID 14179354.  http://www.ncbi.nlm.nih.gov/pubmed/14179354
  25. "The basic trypsin inhibitor of bovine pancreas. I. Structure analysis and conformation of the polypeptide chain". Die Naturwissenschaften 57 (8): 389–92. August 1970. doi:10.1007/BF00599976. PMID 5447861. Bibcode: 1970NW.....57..389H.  https://dx.doi.org/10.1007%2FBF00599976
  26. "Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution". Journal of Molecular Biology 89 (1): 73–101. October 1974. doi:10.1016/0022-2836(74)90163-6. PMID 4475115.  https://dx.doi.org/10.1016%2F0022-2836%2874%2990163-6
  27. "Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra. Basic pancreatic trypsin inhibitor". Journal of Molecular Biology 155 (3): 347–66. March 1982. doi:10.1016/0022-2836(82)90009-2. PMID 6176717.  https://dx.doi.org/10.1016%2F0022-2836%2882%2990009-2
  28. "An evaluation of the combined use of nuclear magnetic resonance and distance geometry for the determination of protein conformations in solution". Journal of Molecular Biology 182 (2): 281–94. March 1985. doi:10.1016/0022-2836(85)90346-8. PMID 2582141.  https://dx.doi.org/10.1016%2F0022-2836%2885%2990346-8
  29. "Crystallographic Refinement of the Structure of Bovine Pancreatic Trypsin Inhibitor at 1.5 Angstroms Resolution". Acta Crystallographica B 31: 238. 1975. doi:10.1107/S0567740875002415. http://journals.iucr.org/b/issues/1975/01/00/a11880/a11880.pdf. 
  30. "Dynamics of folded proteins". Nature 267 (5612): 585–90. June 1977. doi:10.1038/267585a0. PMID 301613. Bibcode: 1977Natur.267..585M.  https://dx.doi.org/10.1038%2F267585a0
  31. "NMR investigations of the dynamics of the aromatic amino acid residues in the basic pancreatic trypsin inhibitor". FEBS Letters 50 (2): 265–8. February 1975. doi:10.1016/0014-5793(75)80504-7. PMID 234403.  https://dx.doi.org/10.1016%2F0014-5793%2875%2980504-7
  32. Creighton, Thomas E. (1992). Protein Folding. W. H. Freeman. ISBN 978-0-7167-7027-5. 
  33. "Increased permeability of blood-brain barrier is mediated by serine protease during Cryptococcus meningitis". The Journal of International Medical Research 42 (1): 85–92. February 2014. doi:10.1177/0300060513504365. PMID 24398759.  https://dx.doi.org/10.1177%2F0300060513504365
  34. Bojkova, Denisa; Bechtel, Marco; McLaughlin, Katie-May; McGreig, Jake E.; Klann, Kevin; Bellinghausen, Carla; Rohde, Gernot; Jonigk, Danny et al. (2020). "Aprotinin Inhibits SARS-CoV-2 Replication". Cells 9 (11): 2377. doi:10.3390/cells9112377. ISSN 2073-4409.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7692688
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Cell Biology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
HandWiki
View Times: 1.5K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 20 Oct 2022
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback